KRT17 and neoplasm: In the CK17 high group, the mean and median percentage of strong (3+) CK17 positive tumor cells were 73.8% (SD 38.3) and 100% (IQR 65) vs. 7.2% (SD 10.7) and 1% (IQR 10.0) in the CK17 low group, p < 0.001.